Idea to IPO and Beyond
Designed for scientists and clinicians interested in entrepreneurship and creating value for their biomedical inventions, this program advances the development of innovative ideas. The course will concentrate on practical information and exercises key topics including:
Attracting Financing Sources; Protecting Intellectual Property; Conducting Market Assessments; Building Corporate Structures; Understanding Regulatory Issues; Developing Elevator Pitches; and Creating Business Plans. Teams will be formed around real technologies with formal end-of-class presentations to a panel of prominent venture capitalists. Application deadline-December 12, 2008!
DATES: January 5, 2009 - March 16, 2009 (Monday from 4:00 PM to 6:00 PM Contact E-Mail: cbe@research.ucsf.edu
15th CMC Strategy Forum - January 11, 2009 - a CASSS conference - San Francisco, California
Read more»
PepTalk - January 11-16, 2009 - a Cambridge Healthtech Institute conference - San Diego, California
The Definitive Protein-Focused Event is once again bringing together life science leaders from around the world to discuss the latest developments and successful strategies for pumping up the biopharm pipeline. PepTalk’s warm and welcoming atmosphere enhances the first-rate selection of in-depth presentations and abundant networking.
Whether your interest lies in early discovery or downstream development, PEPTALK is a “must attend event” to determine the future direction of your work and further your research objectives. Read more»
WCBP 2009: 13th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products - January 12-14, 2009 - a CASSS conference - San Francisco, California
Symposium Co-Chairs: Barry Cherney, CDER, FDA, Philip Krause, CBER, FDA, Wassim Nashabeh, Genentech, Inc.
Read more»
11th Annual Corporate Venturing & Strategic Investing Conference - January 19-20,2009 - an International Business Forum conference - Palm Springs, California
TOPICS TO BE ADDRESSED: • Understanding Today’s Corporate Venturing Activities And Strategies • Spinning Out The Corporate Venturing Arm Into An Independent Fund • Deal Partnerships: Co-Investing And Syndication With Venture Capitalists • Corporate Perspectives On IP Monetization Strategies • M&A Corporate Dealmakers Discuss Business Goals, Targets And M&A Strategies • How Corporations Are Partnering With Universities And Research Labs • Alliances For Emerging Markets (China And India) • Benchmark Metrics And Success For Measuring Innovation Performance • Corporations As Strategic Limited Partners • Innovative Ways To Mix Business And Equity Terms In A Transaction
Read more»
Life Science Angel Investor's Panel- January 26, 2008 - Palo Alto, CA
Life science angel investors are generally seasoned executives with deep strategic and operational experience in running successful life science businesses, from concept to clinical trials to regulatory approvals, manufacturing and distribution. They generally also have extensive experience within corporations in various roles, and continue to develop these partnerships as they support their portfolio companies.
Management of Cleanrooms in FDA Regulated Industry - January 26, 2008 - a Microrite event - San Jose BioCenter -
This half day training will address the following: Cleanroom design considerations from a contamination prevention perspective, contamination sources, required cleanroom maintenance procedures for consistent performance qualification of cleanrooms, environmental monitoring to meet regulatory requirements. disinfectant choice, and cleanroom cleaning challenges and procedures.
Read more»
BioBasics Briefing - January 29 - 30, 2009
The BioBasics Briefing provides two days of biotechnology information for non-science professionals. Learn the science, techniques, applications and issues driving the biotechnology industry today. Lecture and discussion combined with hands-on activities ensures a productive learning environment. Join BayBio and BioTech Primer for the BioBasics Briefing and Learn the Basics of Biotech! Topics covered: Industry Sectors, DNA, Proteins, Gene Expression, Transgenic Technology, Disease and Therapeutic Strategies, Pharmacogenomics, Drug Discovery and Development, and Stem Cells. Technologies: Recombinant DNA, Gel Electrophoresis, PCR, DNA Fingerprinting and MicroArrays.
MSB 2009: 23rd International Symposium on MicroScale Bioseparations - February 1-5, 2009 - a CASSS conference - Boston, MA
Symposium Chair: Jonathan Sweedler, University of Illinois.
Read more»
Auditing GMPS related to Microbiology in Manufacturing in Pharmaceuticals, Medical Device and Biotechnology - February 2009 - This half day training will address the following: Putting together an audit team for microbiology related audits, Quality Systems Inspection Technique (QSIT) approach for auditing Management Controls, Facility Controls, Equipment Controls, Process Controls, Materials Controls, Laboratory Controls and auditing microbiological data deviations and their traceability for lot release and product reviews.
Read more»
Medical Device Breakfast Series | Accelerated Clinical Trials - February 10, 2009
BayBio Medical Device Breakfast Series is designed to showcase up and coming Northern California medical device companies, exciting new technologies behind their work, as well as their pipelines of medical device products. BayBio Medical Device Breakfasts are held second Tuesday every month with each meeting focusing on up to three Northern California companies. Q&A, as well as the networking time will be provided following company presentations. Additionally breakfast meetings will be devoted to a discussion of the issues important to the healthy development of medical device industry and companies.
Venture Spotlight | Investments in BioPlastics & BioMaterials - February 12, 2009
As the global market continues to shift towards more sustainable energy and material sources, bioplastics, or biopolymers, continue to become a viable alternative to traditional petroleum-based polymers. According to BASF, global plastic consumption is estimated to reach 500 billion pounds by 2010, and with current green market trends bioplastics have the potential to be an alternative to this behemoth industry. The BayBio Institute, in partnership with the NYSE, presents the BayBioNEST Venture Spotlight Series. This unique forum allows investors to speak directly to entrepreneurs in a reverse pitch format. Investors have the pulpit to discuss their current interests, target markets, therapies and technologies, as well as the maturation level of typical companies of interest. In Palo Alto.
BayBioNEST Tech Showcase and Networking Reception | Children's Hospital & Research Institute in Oakland - February 19, 2009
The Tech Showcase introduces the life sciences community to a wave of cutting-edge research that will shape the future of the industry. Don’t miss this opportunity to get a sneak peak at early science from a world class research institute, and to connect with faculty, life scientists, and a range of industry executives and professionals. Children’s Hospital Oakland Research Institute, or CHORI, is the internationally renowned biomedical research institute of Children's Hospital & Research Center Oakland. Bridging basic science and clinical research in the treatment and prevention of human disease, CHORI is a leader in translational research, providing cures for diseases, developing new vaccines for infectious diseases, and discovering new treatment protocols for previously fatal or debilitating conditions.
Understanding the Chalenges in Microbial Identification - February 19 and 20, 2009 - a Microrite event - Crowne Plaza, Foster City, California -
This information filled practical workshop will discuss conventional microbiology identification methods, automated phenotypic and genotypic systems and the pitfalls in relying on one system for identification. Using case studies and experience of the speakers the benefits of the polyphasic approach will be explained. Using high quality digital pictures, reference material, and keys developed by Microrite, the correct method of identifying fungal isolates will be taught. Attendees will walk away with a better understanding of microbial identification and skills to detect incorrect microbial identification results.
Read more»
Molecular Medicine Tri – Conference - February 24-27, 2009 – a Cambridge Healthtech Institute conference - San Francisco, California
Read more»
Intensive Training in Environmental Monitoring, Disinfectant Qualification, and Cleanroom Contamination Control - March 5 and 6, 2009 - Caribe Hilton, San Juan, Puerto Rico - This two day practical workshop will discuss the current trends in Environmental Monitoring including sample site choice, frequency, materials and methods, addressing both US and EU guidances. Strategies for qualifying new cleanroom and protocol contents will also be presented. Cleanroom disinfection program including choice of disinfectants, advantages, disadvantages of each disinfectant, disinfectant qualification studies, protocols, reports and cleanroom cleaning procedures will be discussed.
Read more»
Corrective Action Preventive Action (CAPA) - March 2009 - a Microrite event - San Jose BioCenter
This half day course will include, introduction to Corrective Action Preventive Action program and definitions, requirements for CAPA, analysis in the CAPA System, investigations in the CAPA System, Documentation, Records, and Tools, Cause Analysis: Investigating Causes and Solving Problems, Problem Prevention: Ensuring Successful Implementation, Simulations and Case Studies, CAPA System from an FDA Perspective, Effectiveness Checks and Timeliness, Management Oversight and Review. The participants will discuss and develop the critical elements for a CAPA standard operating procedure.
Read more»
Medical Device Breakfast Series | Emerging Surgical Techniques - March 10, 2009
BayBio Medical Device Breakfast Series is designed to showcase up and coming Northern California medical device companies, exciting new technologies behind their work, as well as their pipelines of medical device products. BayBio Medical Device Breakfasts are held second Tuesday every month with each meeting focusing on up to three Northern California companies. Q&A, as well as the networking time will be provided following company presentations. Additionally breakfast meetings will be devoted to a discussion of the issues important to the healthy development of medical device industry and companies.
Drug Discovery Chemistry - April 6-8, 2009 – a Cambridge Healthtech Institute conference - San Diego, California
Read more»
PEGS: The Essential Protein Engineering Summit - April 6-10, 2009 – a Cambridge Healthtech Institute conference - Boston, MA
PEGS 2008 – the essential protein engineering summit – covered topics ranging from discovery to reaching the market. The expanded program incorporated the preclinical and clinical development of antibodies and showcased methods for evaluating the immunogenicity of new classes of biomolecules. The five-day, three-track agenda highlighted the newest approaches and technologies in the field of life science that will enable the next generation of biologics. This year’s event also featured the first symposium on protein tomography, and showed how scale-up, manufacturing and delivery issues need to be considered early in the process of engineering antibodies and biomolecules. This is the largest forum focused entirely on protein engineering science to help you solve the problems you face today, and choose a pathway forward for tomorrow. Read more»
BayBio2009 | Life Sciences – Branching Out - April 16, 2009
The BayBio2009 conference focuses on emerging technologies positioned to address today’s and tomorrow’s critical healthcare, manufacturing and environmental concerns, such as skyrocketing health care costs, worldwide food and fuel shortages, escalating manufacturing costs and global competitiveness. The BayBio2009 conference examines novel solutions to which life sciences companies turn in order to survive harsh economic times. The conference focuses on new organizational partnerships that allow life sciences flourish in an environment of increasing financial and regulatory demands. It examines practical application of new ideas and tools in order to increase efficiencies and shorten bench to bedside cycle. Several industry keynote speakers will address issues of importance to the life sciences professionals. A closing reception will provide a perfect opportunity to network with the industry peers.
Bioscience Business and Marketing Essentials - April 16-17, 2009 - a UCSC Extension course - Cupertino, California
The bioscience industry is like no other. Lengthy timelines and unique financial, legal, regulatory, social, political, and healthcare-system challenges impose constraints that impact every aspect of the business. This course will help you understand the dynamic bioscience industry landscape; appreciate important business drivers and challenges in the industry; gain insight into the critical roles that business and marketing disciplines play at all stages of a bioscience company's development; and learn the skills needed to develop key documents to inform important business decisions. Experienced and novice business and marketing professionals--as well as scientific, clinical, regulatory, financial and legal professionals--can benefit from this practical introduction to the business and marketing facets of the bioscience industry.
Read more»
Bio-IT World Conference & Expo - April 27-29, 2009 – a Cambridge Healthtech Institute conference - Boston, MA
The Sixth Annual Bio-IT World Conference & Expo took place April 28-30, 2008 at the World Trade Center in Boston, Massachusetts, and was a resounding success.
Over 1,500 attendees from 23 countries participated during the course of the event. The event featured five concurrent tracks with over 100 technology and scientific presentations. Read more»
BioMarker World Congress - May 27-29, 2009 – a Cambridge Healthtech Institute conference - Philadelphia, PA
Tracks: Biomarkers in Early Drug Development | Biomarkers in Clinical Development | Biomarkers for Molecular Diagnostics | Biomarker Assay Development. Read more»
20th Annual Venture Capital Investing Conference - June 3-5,2009 - an International Business Forum conference - San Francisco, California
Uniting over 400 of the most active venture capitalists, limited partners and private equity investors representing over a $trillion in capital.
Providing the unique opportunity to hear leading-edge strategies on investing strategies, maximizing returns, best practices, industry trends, ensuring successful fundraising and optimizing exits. Planned with the assistance of our prestigious advisory board, the IBF Venture Capital Investing conference boasts an unparalleled eighteen-year history for quality of program and seniority of speakers and attendees. This industry meeting unites the most active venture investors and institutional investors representing over a $trillion in capital.
Read more»
GeneAcres17 | Current Challenges, Future Opportunities - September 30, 2009
Gene Acres is a one-day facilities conference featuring timely analysis of issues by professionals from multiple perspectives. From facilities design to security, and from regulatory certification to international operations, Gene Acres conference provides insights into the challenges faced by life science companies every day. A closing reception will provide a perfect opportunity to network with your peers.
Pantheon Ceremony Presenting DiNA Awards - November 12, 2009
Each year BayBio recognizes achievement and honors excellence in the life sciences industry in Northern California, as it brings together Northern California’s life sciences industry leaders. The Pantheon Awards Ceremony is a celebration of the contributions and achievements of the Bay Area, a moment in time to pause and reflect on the industry's legacy over three decades. The 2009 DiNA Awards (Northern California's life science Oscar) will be presented to the industry executives and stakeholders who played a key role in life science advancements in Northern California throughout the year.
|